Wearable Technology for Bladder Cancer Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial uses wearable technology to help doctors monitor patients recovering from bladder surgery. Participants will wear a Fitbit Sense 2 and answer health-related questions on their smartphones. The study aims to determine if doctors can quickly respond to concerning health changes detected by the Fitbit, such as changes in heart rate or breathing. This trial may suit individuals who speak English, own a smartphone, and are scheduled for bladder surgery at a UPMC hospital. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance post-surgery care.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on using a fitness tracker and answering questionnaires, so it's unlikely that your medications will be affected.
What prior data suggests that this wearable technology is safe for patients recovering from cystectomy?
Research has shown that using Fitbit Sense 2 devices to monitor patients after bladder surgery is generally safe. In past studies, patients used similar fitness trackers to monitor their activity and heart rate post-surgery. These studies found that wearables can be useful for this purpose, even if they aren't perfect for detailed medical tracking.
The Fitbit Sense 2 tracks steps and heart rate, which can help healthcare providers detect unusual changes, such as a shift in heart rate. While primarily designed for fitness, these devices can provide helpful data for recovery.
No major safety concerns have been reported with using the Fitbit Sense 2. The risk remains low because it is a wearable device commonly used daily for fitness. Since the device does not interfere with the body, it is unlikely to cause any harmful effects.12345Why are researchers excited about this trial?
Researchers are excited about the use of the Fitbit Sense 2 for bladder cancer recovery because it offers continuous remote monitoring of patients' health after surgery. Unlike traditional follow-up methods that rely on periodic in-person visits, this wearable technology continuously collects and transmits biometric data, allowing for timely interventions if any abnormalities are detected. Additionally, the integration of daily smartphone surveys helps keep healthcare providers informed in real-time, enabling them to respond swiftly within 24 hours if necessary. This approach aims to enhance patient care by providing personalized and immediate attention, potentially improving recovery outcomes.
What evidence suggests that this wearable technology is effective for bladder cancer recovery?
Research has shown that Fitbit devices can help monitor recovery after surgeries like cystectomy. One study found that patients who walked more during recovery were less likely to return to the hospital within 30 and 60 days. Tracking activity levels can therefore aid in managing post-surgery care. In this trial, participants will use the Fitbit Sense 2 along with smartphone surveys to monitor their recovery. While devices like the Fitbit have potential, some research suggests they might not be suitable for every aspect of post-surgery monitoring. Overall, using a Fitbit to track activity and health during recovery could help predict and possibly prevent complications, making it a promising tool for patients after a cystectomy.12346
Who Is on the Research Team?
Matthew R Epstein, MD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for individuals recovering from cystectomy, a surgical procedure to remove the bladder. Participants should be comfortable using a Fitbit Sense 2 and a smartphone app to track health data and complete surveys before surgery and for 30 days after hospital discharge.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Pre-surgery Monitoring
Participants set up and use a Fitbit Sense 2 device and complete questionnaires for up to 2 weeks prior to surgery.
Post-surgery Monitoring
Participants use a Fitbit Sense 2 device and complete daily questionnaires for 30 days following discharge to monitor biometric data and trigger alerts.
Follow-up
Participants are monitored for safety and effectiveness after the post-surgery monitoring period.
What Are the Treatments Tested in This Trial?
Interventions
- Fitbit Sense 2
Trial Overview
The study tests if it's feasible for healthcare providers to react quickly to abnormal health signs detected by wearables like Fitbit in patients post-cystectomy. It also aims to find early biomarker patterns that could predict complications leading to readmission.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants undergoing remote monitoring following cystectomy using Fitbit sense 2 device for continuous biometric marker collection and transmission and completion of daily PRO questionnaires administered via smartphone application to trigger provider response within 24 hours of predefined threshold abnormalities.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
Citations
1.
trial.medpath.com
trial.medpath.com/clinical-trial/cad38d0422fc636b/nct04314778-improve-mobility-reduce-readmissions-abdominal-surgeryFITBIT Study on Mobility and Readmissions After Radical ...
The median length of stay after a radical cystectomy is 8 days, with 90% being discharged within two weeks. Postoperatively, the baseline step count will be ...
Feasibility of wearable activity trackers in cystectomy ...
Postoperative activity and heart rate monitoring in cystectomy patients is feasible though current wearables are not well suited for this task.
3.
urologytimes.com
urologytimes.com/view/study-shows-feasibility-of-mobile-app-for-patients-recovering-from-cystectomyStudy shows feasibility of mobile app for patients ...
The mHealth mobile app provides patients with incremental education on post-cystectomy recovery, delivering information at various timepoints ...
Trial Protocol Preoperative Physical Activity Improvement ...
Consequently, it shows cancer-specific 10-yr survival rates of 71.5% (pT2) and 43.7% (pT3) [6]. However, with one in five patients experiencing a serious ...
Fitbit step counts during inpatient recovery from cancer ...
Higher Fitbit step counts during inpatient recovery predicted lower risk of 30- and 60-day readmission after surgery for metastatic peritoneal ...
A Clinical Study Protocol of the PreAct Trial
It hypothesises the use of a fitness tracker–based prehabilitation programme to increase the physical activity of patients prior to radical ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.